Back to Journals » Drug Design, Development and Therapy » Volume 17

Letter

Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]

       
Total article views   HTML views PDF downloads Totals
2,776 Dovepress* 2,678+ 69 2,747
PubMed Central* 98 43 141
Totals 2,776 112 2,888
*Since 5 February 2023

View citations on PubMed and Google Scholar